http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5476771-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6a9431aa1fe5109ca95ad4e332231b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
filingDate 1993-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1995-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb1fd49c64e21d1ae60ecf01091b555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a62dc6cd69c83eb5352157a5aa1d9cb
publicationDate 1995-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5476771-A
titleOfInvention Test for quantitative thrombin time
abstract A quantitative method for determining the plasma levels of thrombin-specific inhibitors is based on the quantitative thrombin time using plasma dilutions, excess fibrinogen and thrombin. The plasma dilutions and excess fibrinogen act in concert to eliminate the effects that coagulopathies have on standard coagulation tests. The method is relatively simple and provides superior results to standard conventional tests. The method is suitable for performance in clinical hematology laboratories on a routine basis using commercially available instrumentation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004224416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016106883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6107097-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5705353-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056722-B1
priorityDate 1993-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4496653-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4067777-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4302538-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4442655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019393-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196404-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8606840-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5053453-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4767742-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4379142-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5118790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196404-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3912805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5187102-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4952562-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4668621-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1508169-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226587668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127897641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13645935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226587669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428143
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127378182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23681217

Total number of triples: 53.